Squarepoint Ops LLC Axcella Health Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.55 - $6.72 $111,006 - $163,947	-24,397 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.24 - $5.97 $208,290 - $293,276	-49,125 Reduced 66.82%	24,397 $127,000
Q3 2020 Nov 16, 2020	BUY	$4.12 - $5.91 $197,611 - $283,467	47,964 Added 187.67%	73,522 $340,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $75,140 - $196,796	25,558 New	25,558 $141,000
Q4 2019 Feb 14, 2020	SELL	$3.08 - $5.9 $31,616 - $60,563	-10,265 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.25 - $9.26 $30,670 - $54,096	-5,842 Reduced 36.27%	10,265 $58,000
Q2 2019 Aug 14, 2019	BUY	$8.51 - $14.95 $137,070 - $240,799	16,107 New	16,107 $150,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.